Israeli politicians focus on foreign threats, ignoring spiralling debt

Israel’s central bank estimates 350bn shekels ($118bn) has been spent on wars (Gaza, Lebanon, Syria) from 2023–2026, excluding the Iran war, and April added 35bn shekels ($11.8bn) for the Iran conflict. Defence spending is rising to 8%+ of GDP (from 5.2% in 2023) while debt is expected to reach ~1.4tn shekels ($480bn) versus 1.07tn shekels ($365bn) pre–Oct 2023, with the IMF warning the 2026 deficit ceiling is too high to stabilize debt. Tax receipts hit a record 509.3bn shekels in 2025 (+12% YoY) but are not keeping pace with defence and debt-service costs, and political pressure in Europe raises default/liquidity risk if bond intermediation is disrupted—implying potential inability to finance weapons.

Analysis

This is primarily a sovereign-funding repricing, not an equity story. The first-order winners are lenders and asset managers outside the local system; the losers are domestic credit intermediaries whose loan growth, deposit pricing, and mark-to-market exposure all move with the government’s borrowing cost. Even if policy makers avoid an explicit crisis, a sustained rise in funding costs should compress multiples across Israel-exposed cyclicals and small caps because higher sovereign yields leak into every private-sector hurdle rate.

Defense is a trap here unless you separate export quality from receivable risk. Contractors tied to foreign orders can still look healthy on backlog, but if the state stretches payment terms, working capital becomes a hidden balance-sheet tax and reported earnings quality deteriorates before revenue does. The cleaner beneficiaries are non-Israeli defense peers with stronger sovereign backstops and faster cash conversion; Israeli names can underperform even while the regional security premium stays elevated.

The key catalyst path is months, not days: budget decisions, rating-agency language, and any failed domestic bond auction matter more than election rhetoric. The real tail risk is a slow erosion of the tax base via capital flight and emigration, which raises the debt ratio even if nominal GDP grows. Contrarianly, the market may be underestimating the political willingness to use taxes and civilian-spending cuts to defend market access; that would cap the downside, but it still implies weaker domestic demand and lower equity ROIC for 6-18 months.

Key Decisions for Investors

• Short EIS on any relief rally or buy 1-3 month puts: this is the cleanest proxy for sovereign-spread and domestic-liquidity stress. Favor a tactical position only if local funding costs keep widening; stop out if the government announces a credible tax/deficit package or ratings remain stable.
• Pair long RTX / short ESLT for a relative-value defense trade: own the global backlog and cleaner balance sheet while fading Israeli receivable and working-capital risk. Best entry is on strength in ESLT; the trade works if sovereign stress persists and contractor payment discipline worsens over the next 1-2 quarters.
• If you need local financial exposure, underweight Israeli banks and insurers via the broad market rather than single names. The mechanism is slower credit growth and higher funding costs; reassess if bond-market access stays intact through the next budget cycle.
• Set alerts on any Israeli sovereign CDS widening or rating outlook change; that is the earliest tradable signal. A sharp move there would justify adding to EIS shorts, while a successful external financing bridge would be the main falsifier.